BeOne Medicines (ONC) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.80% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -3.84% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 34.98% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 47.10% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 38.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.43% |
| Dec 31, 2025 | 29.05% |
| Sep 30, 2025 | 30.53% |
| Jun 30, 2025 | 29.40% |
| Mar 31, 2025 | 26.05% |
| Dec 31, 2024 | 36.41% |
| Sep 30, 2024 | 34.81% |
| Jun 30, 2024 | 36.95% |
| Mar 31, 2024 | -79.43% |
| Dec 31, 2023 | 9.79% |
| Sep 30, 2023 | 35.62% |
| Jun 30, 2023 | -3.23% |
| Mar 31, 2023 | 2.83% |
| Dec 31, 2022 | -3.30% |
| Sep 30, 2022 | -19.78% |
| Jun 30, 2022 | -76.24% |
| Mar 31, 2022 | -33.73% |
| Dec 31, 2021 | -28.08% |
| Sep 30, 2021 | -40.64% |
| Jun 30, 2021 | -45.21% |
| Mar 31, 2021 | 38.13% |
| Dec 31, 2020 | -63.91% |
| Sep 30, 2020 | -78.79% |
| Jun 30, 2020 | -78.87% |
| Mar 31, 2020 | -95.76% |
| Dec 31, 2019 | -120.68% |
| Sep 30, 2019 | -109.08% |
| Jun 30, 2019 | -62.41% |
| Mar 31, 2019 | -102.24% |
| Dec 31, 2018 | -117.70% |
| Sep 30, 2018 | -124.06% |
| Jun 30, 2018 | -202.98% |
| Mar 31, 2018 | -117.17% |